HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aesthetic Medicine

869.902

-13.531-1.53%

Number of Gainers:1

Number of Losers:12

Number of Flat:- -

PE:- -

High:884.356

Open:882.809

Low:858.346

Close:883.433

Volume:69.96M

Turnover:709.51M

Market Cap:144.60B

Float Cap:106.74B

Loading ...

Longchuan Zone of Ruili Industrial Cooperation Park Reports Strong Performance in First Half

Angelalign Announces Extraordinary General Meeting

Angelalign Shareholders to Vote on 1,255,803 RSU Grants to Three Executive Directors at Sept. 30 EGM

Angelalign Grants 1.56 Million Restricted Share Units to Eligible Participants

Fosun Pharma's Subsidiary Sees Regulatory Acceptance for Denosumab Biosimilar Candidate HLX14

Fosun Pharma Spends Approximately HK$21.86 Million on Share Buyback

3SBio Allocates HK$62.6 Million to Buy Back 4 Million Shares

3SBio Files HKEX Next-Day Disclosure Return Reporting Share Repurchase

HAOHAI BIOTEC Spends Approximately HK$795,700 on Share Buyback

AH Share Premium Rankings: September 10 Market Close Update

Pharmaceutical Firms Divest Assets to Bolster Core Operations

Fosun Pharma's New Oral Drug for Vitiligo Gets Green Light for Phase III Trials

Fosun Pharma Spends HK$2.63 Million Buying Back Shares on September 9

CMS: Initial Prescriptions for Silevimig Injection, the World’s First Bispecific Antibody Against Rabies, Issued in China

Sinopharm Group Stock Slips 2.1% in Hong Kong

UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick

HAOHAI BIOTEC (06826) Spends HK$529,300 to Buy Back 31,500 Shares on September 8

Shanghai Fosun Pharma - Receives Nmpa Approval for Phase Ii/Iii Clinical Trial of Fxs5626

THOMSON REUTERS

Fosun Pharma's Subsidiary Obtains Regulatory Nod for FXS5626 Tablet Trial in Vitiligo Indication

Fosun Pharma Spends HK$1.18M on Share Buyback on September 7

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BK1593/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":869.9022,"timestamp":1789114133774,"preClose":883.43335,"halted":0,"volume":69960617,"delay":0,"changeRate":-0.015317,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-13.531128,"latestTime":"09-11 16:00:00","open":882.80945,"high":884.35583,"low":858.3457,"amount":709509713,"amplitude":0.029442,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":1.117247,"peRate":10.209827,"turnoverRate":0.003127,"increases":1,"decrements":12,"flats":0,"marketCap":144597722624,"floatMarketCap":106735221760},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":884.35583,"amplitude":0.029442,"preClose":883.43335,"low":858.3457,"pbRate":"1.117247","latestPrice":869.9022,"volume":69960617,"delay":0,"open":882.80945,"prevYearClose":1094.978,"prevWeekClose":913.749,"prevMonthClose":902.195,"prevQuarterClose":846.145,"fiveDayClose":913.749,"twentyDayClose":957.712,"sixtyDayClose":841.957,"secType":"PLATE","market":"HK","turnoverRate":0.003127,"peRate":10.209827,"marketCap":144597722624,"floatMarketCap":106735221760,"timestamp":1789114133774,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":1,"down":12,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1172195316","title":"Longchuan Zone of Ruili Industrial Cooperation Park Reports Strong Performance in First Half","url":"https://stock-news.laohu8.com/highlight/detail?id=1172195316","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172195316?lang=en_us&edition=fundamental","pubTime":"2026-09-12 17:00","pubTimestamp":1789203630,"startTime":"0","endTime":"0","summary":"The Longchuan Zone of the Yunnan Ruili Industrial Cooperation Park delivered an impressive set of results in the first half of 2026. Industrial output reached 1.743 billion yuan, marking a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02135","BK1593","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666652209","title":"Angelalign Announces Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666652209","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666652209?lang=en_us&edition=fundamental","pubTime":"2026-09-11 21:10","pubTimestamp":1789132230,"startTime":"0","endTime":"0","summary":"Angelalign announces extraordinary general meetingAngelalign Technology will hold an extraordinary general meeting in Shanghai on Sept. 30, 2026.Shareholders will vote on proposed RSU grants totaling ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL5fmybf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1583","06699","BK1593","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666522484","title":"Angelalign Shareholders to Vote on 1,255,803 RSU Grants to Three Executive Directors at Sept. 30 EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2666522484","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666522484?lang=en_us&edition=fundamental","pubTime":"2026-09-11 21:00","pubTimestamp":1789131608,"startTime":"0","endTime":"0","summary":"Angelalign shareholders to vote on 1,255,803 RSU grants to three executive directors at Sept. 30 EGMShareholders meet on Sept. 30, 2026 to vote on one-time, three-year retrospective RSU grants to thre","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL9BXjKG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1587","BK1593","06699","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168838419","title":"Angelalign Grants 1.56 Million Restricted Share Units to Eligible Participants","url":"https://stock-news.laohu8.com/highlight/detail?id=1168838419","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168838419?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:30","pubTimestamp":1789129856,"startTime":"0","endTime":"0","summary":"Angelalign (06699) has announced that its board of directors resolved on September 11, 2026, to award a total of 1,563,900 restricted share units to 16 grantees under the post-IPO restricted share...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1593","06699","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188259168","title":"Fosun Pharma's Subsidiary Sees Regulatory Acceptance for Denosumab Biosimilar Candidate HLX14","url":"https://stock-news.laohu8.com/highlight/detail?id=1188259168","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188259168?lang=en_us&edition=fundamental","pubTime":"2026-09-11 17:50","pubTimestamp":1789120228,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SH) has announced that the drug registration application for its self-developed denosumab biosimilar, HLX14 (recombinant anti-RANKL fully human...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU2272731600.USD","BK1515","BK4585","BK0196","BK0028","PPH","BK0175","IE00B5TLWC47.USD","BK1593","BK0183","BK0096","BK1191","600196","LU2272731865.HKD","BK0188","IBB","BK0187","LU1992135399.USD","LU2322448791.USD","BK0012","LU1992135472.HKD","BK4588","LU2322448957.HKD","02196","LU2272731782.SGD","LU2473716301.USD","XPH","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147370626","title":"Fosun Pharma Spends Approximately HK$21.86 Million on Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1147370626","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147370626?lang=en_us&edition=fundamental","pubTime":"2026-09-11 17:38","pubTimestamp":1789119506,"startTime":"0","endTime":"0","summary":"FOSUN PHARMA (02196) announced on September 11 that it repurchased 1.34 million shares for approximately HK$21.8642 million, at a price range of HK$16.14 to HK$16.5 per share.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600196","BK0187","BK0096","BK1515","BK0012","BK0175","BK0239","BK0183","BK1191","BK0060","BK0196","BK1593","BK0028","BK0188","02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194232555","title":"3SBio Allocates HK$62.6 Million to Buy Back 4 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1194232555","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194232555?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:38","pubTimestamp":1789036693,"startTime":"0","endTime":"0","summary":"In a regulatory filing on Wednesday, 3SBio disclosed its latest share repurchase activity, spending approximately HK$62.63 million to acquire 4 million of its own shares on September 10.This buyback...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","BK1583","BK1161","HK0000165453.HKD","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666673685","title":"3SBio Files HKEX Next-Day Disclosure Return Reporting Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2666673685","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666673685?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:36","pubTimestamp":1789036581,"startTime":"0","endTime":"0","summary":"3SBio files HKEX next-day disclosure return reporting share repurchase3SBio repurchased 4,000,000 ordinary shares on Sept. 10, 2026, holding them as treasury shares.Buyback range HKD 15.5 to HKD 15.75","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL4fyG9G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","01530","BK1583","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117842310","title":"HAOHAI BIOTEC Spends Approximately HK$795,700 on Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1117842310","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117842310?lang=en_us&edition=fundamental","pubTime":"2026-09-10 17:44","pubTimestamp":1789033451,"startTime":"0","endTime":"0","summary":"HAOHAI BIOTEC (06826) announced that on September 10, 2026, it utilized approximately HK$795,700 to repurchase 48,000 shares of the company.The buyback transaction reflects the company's ongoing...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120089169","title":"AH Share Premium Rankings: September 10 Market Close Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1120089169","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120089169?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:23","pubTimestamp":1789028611,"startTime":"0","endTime":"0","summary":"As of the market close on September 10, data reveals the latest rankings for A-H share premium ratios, with NE Electric (00042), ZHEJIANG SHIBAO (01057), and HOLLY FUTURES (03678) claiming the top...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014674.SGD","LU0314109678.HKD","BK1552","LU1303224171.USD","LU1244550221.USD","LU1993786604.SGD","83188","LU0543330483.HKD","IE00BZ08YT58.USD","LU0173614495.USD","LU0531970944.HKD","LU0516422366.SGD","LU0149534421.HKD","LU0737861772.HKD","IE00BF5LJ272.USD","06826","LU1282649810.SGD","06745","LU0164939612.USD","BK1191","LU0320764755.SGD","00300","LU0359201612.USD","399300","82846","IE00BZ08YS42.EUR","BK1148","LU0634319403.HKD","03750","EWH","LU0828238088.HKD","BK1105","06821","LU1328277881.USD","LU1152091754.HKD","BK1583","LU0214875030.USD","LU2097828474.EUR","BK1551","LU0540923850.HKD","BK1544","LU1481107354.HKD","03200","BK1171","LU0051755006.USD","LU0307460666.USD","LU1719994722.HKD","SG9999002463.SGD","LU1188198961.HKD","LU0211977185.USD","BK1564","LU0797268264.HKD","LU2097828631.EUR","00317","03968","LU1105468828.SGD","LU0052750758.USD","LU0029875118.USD","SG9999004220.SGD","HK0001040143.USD","LU0106252389.USD","LU2097828714.EUR","LU1769817096.USD","BK1574","LU1366334578.USD","LU0449509016.USD","LU1282649141.HKD","BK1190","LU0359201885.HKD","HK0000306701.USD","HK0000306685.HKD","LU1251922891.USD","LU0979878070.USD","IE00BMCWC346.EUR","BK1144","LU0828237510.HKD","BK1546","IE00BVYPNQ40.USD","BK1147","LU0164880469.USD","06869","BK1562","LU1831875114.USD","LU2264538146.SGD","BK1592","LU1115378108.SGD","LU0082770016.SGD","BK1183","LU0516423174.USD","LU0828237940.HKD","LU0531971595.HKD","LU0791591158.USD","IE0034224299.USD","HK0000352291.HKD","LU0918141887.USD","LU1224709979.USD","LU0228367735.SGD","LU2177674079.SGD","BK1537","BK1560","LU0791590937.USD","BK1163","02827","LU1064131342.USD","LU0456846285.SGD","LU0348766576.USD","00187","BK1122","LU0463099449.HKD","03130","BK1576","LU1688375341.USD","01033","LU0455707207.USD","LU0880133367.SGD","LU0417516738.SGD","01812","07233","LU0348827113.USD","LU0149721374.USD","BK1507","LU1282649067.USD","LU0516422440.USD","BK1214","LU1206782309.USD","LU0469268626.HKD","LU0516423091.SGD","LU1960683339.HKD","LU1769817179.HKD","SG9999002828.SGD","LU2097828805.USD","LU0254981946.USD","LU0890818403.SGD","LU0266512473.USD","IE00B29SXG58.USD","LU1808992512.USD","LU0572944931.SGD","LU1048596156.SGD","LU2242644610.SGD","LU1282648689.USD","LU0648948544.HKD","LU2476274720.SGD","LU0348816934.USD","HK0001040168.HKD","SG9999006597.SGD","LU0501845795.SGD","BK1110","IE0008368742.USD","01349","LU1242518931.SGD","LU0359202008.SGD","IE00B5MMRT66.SGD","LU1794554557.SGD","03986","LU0181495838.USD","LU2394011477.USD","00895","LU0228659784.USD","LU0370786039.SGD","LU3063872942.SGD","LU1226287529.USD","LU0607220059.USD","LU0516422952.EUR","LU0043850808.USD","LU0509642566.USD","01108","LU0287142896.SGD","BK1125","BK1533","HK0000320264.USD","LU1504937902.USD","IE0032431581.USD","LU1720050803.USD","BK1594","SG9999001226.SGD","LU0348805143.USD","BK1141","LU0067412154.USD","LU1046422090.SGD","BK1610","02846","BK1202","LU0164865239.USD","LU1880383366.USD","BK1505","LU1961090484.USD","LU0868486357.SGD","LU0231483743.USD","BK1161","LU0672654166.SGD","LU0589944569.HKD","83130","LU0823426308.USD","LU0266512127.USD","BK1223","LU0348767384.USD","LU0072913022.USD","LU0737861699.HKD","LU0821914370.USD","LU0326950275.SGD","LU0096374516.USD","02475","HK0000352382.USD","02899","IE0008369823.USD","LU0210526637.USD","LU0871576103.HKD","LU2045819591.USD","LU0329678170.USD","IE00B031HY20.USD","BK1523","LU0106959298.USD","LU2294711473.HKD","SG9999001093.SGD","LU0165289439.USD","01057","03678","LU2226246903.HKD","06185","LU0163747925.USD","SG9999011746.SGD","LU0345780281.USD","LU1023057109.AUD","LU0456854461.SGD","LU1988902786.USD","IE0031814852.USD","IE00BGHQDM52.EUR","LU2476274308.USD","LU0384037296.USD","LU2125910500.SGD","LU0488056044.USD","LU0708995583.HKD","BK1249","IE00B543WZ88.USD","IE00B031J352.USD","LU1242518857.USD","LU1807302812.USD","LU0543330566.HKD","LU0417516902.SGD","LU0620787316.HKD","LU1880383440.USD","BK1593","BK1149","LU0140636845.USD","LU0431992006.USD","BK1521","LU0561508036.HKD","BK1514","03143","LU1152091168.USD","LU0348814723.USD","01877","LU0456827905.SGD","LU0039217434.USD","02359","LU2039709279.SGD","LU2778985437.USD","BK1515","LU1244550494.USD","LU1366334651.USD","BK1170","LU0640798160.USD","LU0348788117.USD","00553","HK0000320223.HKD","LU0348825331.USD","BK1116","BK1530","02865","BK1554","IE00B0169L03.USD","LU0348735423.USD","LU0320764599.SGD","LU0593848301.USD","LU0117841782.USD","LU0244354667.USD","BK1198","LU0329678337.USD","00991","IE00BVYPNP33.GBP","LU2399975544.HKD","LU0345780521.USD","LU1255011170.USD","IE00BYV24P56.USD","LU0588546209.SGD","IE00B3M56506.USD","LU0502904849.HKD","LU0315179316.USD","LU1008478684.HKD","03308","LU1244550577.SGD","03328","LU0061477393.USD","159982","LU1655091616.SGD","LU0229945570.USD","LU0918141705.HKD","LU1770034418.SGD","02068","LU0886674414.USD","LU0049853897.USD","02338","LU0269904917.USD","06066","03188","LU1675838814.USD","LU1813983027.USD","BK1506","02218","LU0082770016.USD","BK1522","LU0328353924.USD","LU0823426480.USD","LU1211504680.USD","LU0048580855.USD","LU2097828557.USD","IE00BZ08YR35.GBP","LU0128522157.USD","BK1140","BK1231","LU0862451753.SGD","00042","LU2008162690.USD","LU0327786744.USD","BK1237"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169429326","title":"Pharmaceutical Firms Divest Assets to Bolster Core Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=1169429326","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169429326?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:12","pubTimestamp":1788966731,"startTime":"0","endTime":"0","summary":"A growing number of domestic listed pharmaceutical companies have recently disclosed asset disposal announcements, planning to sell partial or full equity stakes in their controlled subsidiaries....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","02196","BK1574","BK4202","BK1191","FOSL","BK1593","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108076077","title":"Fosun Pharma's New Oral Drug for Vitiligo Gets Green Light for Phase III Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1108076077","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108076077?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:21","pubTimestamp":1788956512,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. has announced that its oral candidate FXS5626 tablets (formerly project code AC-201) have received clinical trial approval from the National Medical...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0096","BK0028","BK1515","02196","BK0196","BK0183","BK0012","BK0239","BK1191","BK1593","BK0188","600196","BK0060","BK0187","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156059034","title":"Fosun Pharma Spends HK$2.63 Million Buying Back Shares on September 9","url":"https://stock-news.laohu8.com/highlight/detail?id=1156059034","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156059034?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:06","pubTimestamp":1788948375,"startTime":"0","endTime":"0","summary":"Fosun Pharma (02196) has announced that on September 9, 2026, the company repurchased 152,500 shares for a total consideration of HK$2.63 million.The buyback transaction was disclosed in an official...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK0188","BK0187","BK0175","BK0239","600196","BK0183","BK0196","BK1515","BK0060","BK1593","BK1191","BK0028","02196","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666581721","title":"CMS: Initial Prescriptions for Silevimig Injection, the World’s First Bispecific Antibody Against Rabies, Issued in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2666581721","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666581721?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:41","pubTimestamp":1788946860,"startTime":"0","endTime":"0","summary":"SHENZHEN, CHINA, Sept.  09, 2026 (GLOBE NEWSWIRE) -- On 9 September, China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS” or the “Group”) is pleased to announce that the initial prescriptions ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358397/0/en/cms-initial-prescriptions-for-silevimig-injection-the-world-s-first-bispecific-antibody-against-rabies-issued-in-china.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867","SG9999004220.SGD","IE00BVYPNQ40.USD","SG9999015986.USD","LU2488822045.USD","SG9999015978.USD","SG9999004311.SGD","BK1191","IE00BMCWC346.EUR","IE00BVYPNP33.GBP","BK1593","IE00BGHQDM52.EUR","SG9999015952.SGD","SG9999015945.SGD","IE00BYV24P56.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458549","title":"Sinopharm Group Stock Slips 2.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458549","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458549?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:32","pubTimestamp":1788942720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slid 2.1% to 15.70 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.The stock's fall snapped a four-day winning streak.Sinopharm Group Co. Ltd. closed 30% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.2%.Trading volume totaled 5.9 million shares, compared to the 50-day average of 5.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","BK1191","BK0175","01099","BK0196","BK1593","BK0012","BK1515","02196","BK0060","LU0640798160.USD","BK0187","BK0239","BK0028","BK0183","BK1197","BK0096","SHTDY","LU1115378108.SGD","BK0188","600196","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143782105","title":"UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick","url":"https://stock-news.laohu8.com/highlight/detail?id=1143782105","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143782105?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:03","pubTimestamp":1788940980,"startTime":"0","endTime":"0","summary":"UBS has released a research report indicating that first-half results among Chinese pharmaceutical stocks were mixed, with five of the nine rated companies exceeding market expectations. These...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1521","02096","03692","BK1583","HK0000165453.HKD","IE00B3M56506.USD","IE00BZ08YR35.GBP","BK1589","01477","BK1574","BK1161","01177","03933","BK1593","IE00BZ08YT58.USD","01530","BK1515","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113076069","title":"HAOHAI BIOTEC (06826) Spends HK$529,300 to Buy Back 31,500 Shares on September 8","url":"https://stock-news.laohu8.com/highlight/detail?id=1113076069","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113076069?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:46","pubTimestamp":1788860773,"startTime":"0","endTime":"0","summary":"HAOHAI BIOTEC (06826) has disclosed that on September 8, 2026, it utilized HK$529,300 to repurchase 31,500 of its own shares.The buyback transaction underscores the company's ongoing capital management strategy and its commitment to enhancing shareholder value through market operations.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06826","BK1161","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665932955","title":"Shanghai Fosun Pharma - Receives Nmpa Approval for Phase Ii/Iii Clinical Trial of Fxs5626","url":"https://stock-news.laohu8.com/highlight/detail?id=2665932955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665932955?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:44","pubTimestamp":1788860689,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN44Z0IU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0060","BK0028","BK0183","BK0096","BK0175","BK0196","BK0188","BK1191","BK1593","BK0012","02196","BK0187","BK0239","BK1515","600196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132147233","title":"Fosun Pharma's Subsidiary Obtains Regulatory Nod for FXS5626 Tablet Trial in Vitiligo Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1132147233","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132147233?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:20","pubTimestamp":1788859248,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SH: 600196) has announced that its controlling subsidiary, Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd., recently received approval...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","PSYK","IBBJ","BK0028","BK0175","IBBQ","BK0060","02196","BK0196","BMED","BK1593","MDTX","BK1191","BK0239","BK0187","BK0096","600196","BK1515","BK0183","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146341626","title":"Fosun Pharma Spends HK$1.18M on Share Buyback on September 7","url":"https://stock-news.laohu8.com/highlight/detail?id=1146341626","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146341626?lang=en_us&edition=fundamental","pubTime":"2026-09-07 18:02","pubTimestamp":1788775333,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. (HK: 02196) has announced a share repurchase transaction executed on September 7, 2026. According to the company's official disclosure, the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600196","BK0028","BK0183","BK0196","BK0060","BK0239","BK1191","BK0175","BK1515","BK1593","BK0012","BK0096","BK0188","02196","BK0187"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":75,"code":"91000000","status":"200"}]}}